Larimar Therapeutics LRMR
NASDAQ LRMR
$2.27 -0.15 (-6.20%)
At close: Oct 22, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Net Preferred Shares Issued and Repurchased (2013 - 2014)

Updated

Analysis

Larimar Therapeutics (LRMR) Net Preferred Shares Issued and Repurchased (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Larimar Therapeutics 234.26 Mn -372.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 442,000.00
Dec 31, 2013 34.84 Mn
API Access

Larimar Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=LRMR&period=max&api_key=YOUR_API_KEY